Hypotensive and lipld regulatory actions of 4-hydroxyderricin, a chalcone from Angelica keiskei, in stroke-prone spontaneously hypertensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 1-2, 2005, Pages 19-23

  Ogawa, Hiroshi ^a   Ohno, Mami ^b   Baba, Kimiye ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

4 hydroxyderricin; Angelica keiskei; Blood pressure; Chalcone; Lipid metabolism; Reverse transcription polymerase chain reaction; Stroke prone spontaneously hypertensive rats

Indexed keywords

4 HYDROXYDERRICIN; ANGELICA KEISKEI EXTRACT; CHALCONE; FATTY ACID; FATTY ACID SYNTHASE; HIGH DENSITY LIPOPROTEIN; LIPID; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PLANT EXTRACT; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; 4-HYDROXYDERRICIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; DRUG DERIVATIVE; ENZYME INHIBITOR; LIPOPROTEIN;

ADOLESCENT; ANGELICA; ANGELICA KEISKEI; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG ACTIVITY; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; LIPID METABOLISM; LIPID REGULATORY ACTION; LIPOPROTEIN BLOOD LEVEL; LIVER WEIGHT; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD PRESSURE; CHEMISTRY; DIET; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LIVER; LIVER MICROSOME; METABOLISM; ORGAN SIZE; PLANT STEM;

ANGELICA; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; APOLIPOPROTEINS; BLOOD PRESSURE; CHALCONE; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIET; ENZYME INHIBITORS; LIPID METABOLISM; LIPOPROTEINS; LIVER; MALE; MICROSOMES, LIVER; ORGAN SIZE; PLANT EXTRACTS; PLANT STEMS; RATS; RATS, INBRED SHR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 14644418992     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04147.x     Document Type: Article

References (22)

1. Murakami S, Kijima H, Isobe Y et al. Inhibition of gastric H(+),K(+)-ATPase by chalcone derivatives, xanthoangelol and 4-hydroxyderricin from Angelica keiskei Koidzumi. J. Pharm. Pharmacol. 1990; 42: 723-6.
2. Okuyama T, Takata M, Takayasu J et al. Anti-tumor-promotion by principles obtained from Angelica keiskei. Planta Med. 1991; 57: 242-6.
3. Fujita T, Sakuma S, Sumiya T et al. The effects of xanthoangelol E on arachidonic acid metabolism in the gastric antral mucosa and platelet of the rabbit. Res. Commun. Chem. Pathol. Pharmacol. 1992; 77: 227-40.
4. Shimizu E, Hayashi A, Takahashi R, Aoyagi Y, Murakami T, Kimoto K. Effects of angiotensin I-converting enzyme inhibitor from Ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 1999; 45: 375-83.
5. Matsuura M, Kimura Y, Nakata K, Baba K, Okuda H. Artery relaxation by chalcones isolated from the roots of Angelica keiskei. Planta Med. 2001; 67: 230-5.
6. Ogawa H, Nakashima S, Baba K. Effects of dietary Angelica keiskei on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol Physiol. 2003; 30: 284-8.
7. Reeves PG, Rossow KL. Development and testing of the AIN-93 purified diets for rodents: Results on growth, kidney calcification and bone mineralization in rats and mice. J. Nutr. 1993; 123: 1923-31.
8. Quarfordt SH, Jain RS, Jakoi L, Robinson S, Shelburne F. The heterogeneity of rat high density lipoproteins. Biochem. Biophys. Res. Commun. 1978; 83: 786-93.
9. Folch J, Lee M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957; 226: 497-509.
10. Ogawa H, Shiota C, Nishikawa T, Fukushima S, Sasagawa S. Age-related changes in serum concentrations of apolipoprotein A-I, E, and A-IV in SHRSP. J. Hypertens. 1986; 4 (Suppl. 3): 429-31.
11. Ogishima T, Okuda K. An improved method for assay of cholesterol 7α-hydroxylase activity. Anal. Biochem. 1986; 158: 228-32.
12. Kamisako T, Ogawa H. Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation. Hepatol. Res. 2003; 25: 99-104.
13. Myant NB, Mitropoulos KA. Cholesterol 7α-hydroxylase. J. Lipid Res. 1977; 18: 135-53.
14. Wetterau JR, Lin MC, Jamil H. Microsomal triglyceride transfer protein. Biochim. Biophys. Acta 1997; 1345: 136-50.
15. Rodwell VW, Nordstrom JL, Mitschelen JJ. Regulation of HMG-CoA reductase. Adv. Lipid Res. 1976; 14: 1-74.
16. Osumi T, Hashimoto T. Acyl-CoA oxidase of rat liver: A new enzyme for fatty acid oxidation. Biochem. Biophys. Res. Commun. 1978; 83: 479-85.
17. Suzuki H, Kawarabayasi Y, Kondo J et al. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 1990; 265: 8681-5.
18. Beck KF, Schreglmann R, Stathopulos I, Klein H, Hoch J, Schweizer M. The fatty acid synthase (FAS) gene and its promoter in Rattus norvegicus. DNA Seq. 1992; 2: 359-86.
19. Desvergne B, Wahli W. Peroxisome proliferator-activated receptor: Nuclear control of metabolism. Endocr. Rev. 2000; 20: 649-88.
20. Tontonoz P, Kim JB, Graves RA, Spiegelman BM. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell Biol. 1993; 13: 4753-9.
21. Letexier D, Pinteur C, Large V, Frering V, Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J. Lipid Res. 2003; 44: 2127-34.
22. Bergstrom JD, Bostedor RG, Rew DJ, Geissler WM, Wright SD, Chao YS. Hepatic responses to inhibition of 3-hydroxy-3 methylglutaryl-CoA reductase: A comparison of atorvastatin and simvastatin. Biochim. Biophys. Acta 1998; 1389: 213-21.